| |
| | Fool.com: Trinity Scores With HIV Test [Motley Fool Take] December 30, 2003 |
 | | Yesterday morning, Ireland-based Trinity Biotech (Nasdaq: TRIB) said it received FDA approval to market its Uni-Gold Recombigen HIV test in the U.S. Since the announcement, its shares have been on a tear, climbing 57% to $5.14 yesterday, and another 22% to $6.30 by early this afternoon. |
 | | The 10-minute, one-step test is for the detection of HIV antibodies in human serum, plasma, or whole blood, and is the only test approved for use in all three sample types. |
 | | Trinity's test is also approved for use in the World Health Organization's HIV testing program in Africa, where the company sells four million tests per year. |
| www.fool.com /News/mft/2003/mft03123011.htm (324 words) |
|